Jianmin Pharmaceutical Group Co.,Ltd.

SHSE:600976 Rapporto sulle azioni

Cap. di mercato: CN¥6.5b

Jianmin Pharmaceutical GroupLtd Gestione

Gestione criteri di controllo 3/4

Jianmin Pharmaceutical GroupLtd Il CEO è Jun Wang, nominato in Sep2022, ha un mandato di 2.17 anni. possiede direttamente 0.23% delle azioni della società, per un valore di CN¥ 14.73M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.2 anni e 2.2 anni.

Informazioni chiave

Jun Wang

Amministratore delegato

CN¥891.4k

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO2.2yrs
Proprietà del CEO0.2%
Durata media del management2.2yrs
Durata media del Consiglio di amministrazione2.2yrs

Aggiornamenti recenti sulla gestione

Recent updates

Potential Upside For Jianmin Pharmaceutical Group Co.,Ltd. (SHSE:600976) Not Without Risk

Nov 10
Potential Upside For Jianmin Pharmaceutical Group Co.,Ltd. (SHSE:600976) Not Without Risk

If EPS Growth Is Important To You, Jianmin Pharmaceutical GroupLtd (SHSE:600976) Presents An Opportunity

Sep 25
If EPS Growth Is Important To You, Jianmin Pharmaceutical GroupLtd (SHSE:600976) Presents An Opportunity

Calculating The Fair Value Of Jianmin Pharmaceutical Group Co.,Ltd. (SHSE:600976)

Aug 25
Calculating The Fair Value Of Jianmin Pharmaceutical Group Co.,Ltd. (SHSE:600976)

The Market Doesn't Like What It Sees From Jianmin Pharmaceutical Group Co.,Ltd.'s (SHSE:600976) Earnings Yet As Shares Tumble 27%

Jul 12
The Market Doesn't Like What It Sees From Jianmin Pharmaceutical Group Co.,Ltd.'s (SHSE:600976) Earnings Yet As Shares Tumble 27%

We Think Jianmin Pharmaceutical GroupLtd (SHSE:600976) Can Stay On Top Of Its Debt

Jun 30
We Think Jianmin Pharmaceutical GroupLtd (SHSE:600976) Can Stay On Top Of Its Debt

We Ran A Stock Scan For Earnings Growth And Jianmin Pharmaceutical GroupLtd (SHSE:600976) Passed With Ease

May 21
We Ran A Stock Scan For Earnings Growth And Jianmin Pharmaceutical GroupLtd (SHSE:600976) Passed With Ease

We Think That There Are Issues Underlying Jianmin Pharmaceutical GroupLtd's (SHSE:600976) Earnings

Apr 26
We Think That There Are Issues Underlying Jianmin Pharmaceutical GroupLtd's (SHSE:600976) Earnings

AMMINISTRATORE DELEGATO

Jun Wang (47 yo)

2.2yrs

Mandato

CN¥891,400

Compensazione

Mr. Jun Wang was Vice President of KPC Pharmaceuticals,Inc until September 08, 2020. He is Managing Director of Jianmin Pharmaceutical Group Co.,Ltd. He is Director and President of Jianmin Pharmaceutical...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Jun Wang
President2.2yrsCN¥891.40k0.23%
CN¥ 14.7m
Chaoyang Cheng
Financial Director2.2yrsCN¥511.20k0.055%
CN¥ 3.6m
Zhenbo Hu
VP & Director1.3yrsCN¥210.40kNessun dato
Jie Zhou
Secretary2.2yrsCN¥408.80k0.024%
CN¥ 1.6m
Xuejun Pei
Vice President2.2yrsCN¥540.00k0.12%
CN¥ 7.8m
Zhijun Huang
Vice President2.2yrsCN¥540.00k0.11%
CN¥ 6.9m

2.2yrs

Durata media

49yo

Età media

Gestione esperta: Il team dirigenziale di 600976 è considerato esperto (durata media dell'incarico 2.2 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Jun Wang
President2.2yrsCN¥891.40k0.23%
CN¥ 14.7m
Zhenbo Hu
VP & Director1.3yrsCN¥210.40kNessun dato
Qin He
Chairman2.2yrsCN¥2.10m0.27%
CN¥ 17.4m
Qijing Xiao
Chairman of the Supervisory Board2.2yrsNessun datoNessun dato
Yunpei Guo
Independent Director2.2yrsCN¥90.00kNessun dato
Rong Pei
Director2.2yrsCN¥60.00kNessun dato
Liang Xu
Director2.2yrsCN¥60.00kNessun dato
Shuqu Li
Independent Director2.2yrsCN¥90.00kNessun dato
Hu Jian
Supervisor2.2yrsNessun datoNessun dato
Li Chen
Supervisor2.2yrsNessun datoNessun dato
Jingqiu Tang
Supervisor2.2yrsNessun datoNessun dato
Zhi Yang
Independent Director2.2yrsCN¥90.00kNessun dato

2.2yrs

Durata media

53.5yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di 600976 non è considerato esperto (durata media del mandato 2.2 anni), il che suggerisce un nuovo consiglio.